SLEEP DISTURBANCE AND QUALITY OF SLEEP AMONG PATIENTS WITH CARDIOVASCULAR DISEASES by Merin, Neenu & Antony, Regina
Vol 12, Issue 1, 2019
Online - 2455-3891 
Print - 0974-2441
SLEEP DISTURBANCE AND QUALITY OF SLEEP AMONG PATIENTS WITH CARDIOVASCULAR 
DISEASES
NEENU MERIN1, REGINA ANTONY2
1M. Sc Nursing Student, Amrita College of Nursing, Amrita Vishwa vidyapeetham, Kochi, Kerala, India,2Department of Medical Surgical 
Nursing, Amrita College of Nursing, Amrita Vishwa vidyapeetham, Kochi, Kerala, India. Email: reginaantony@aims.amrita.edu
Received: 25 July 2018, Revised and Accepted: 17 October 2018
ABSTRACT
Objective: This was a descriptive study with the objective to determine the sleep disturbances and the quality of sleep among patients with 
cardiovascular diseases (CVDs).
Methods: Quantitative approach with non-experimental descriptive design was used. A semi-structured sleep disturbance questionnaire was used to 
determine the sleep disturbances, and a standardized Pittsburgh Sleep Quality Index tool was used to assess the sleep quality among 100 subjects in 
Amrita Institute of Medical Sciences, Kochi.
Results: The study results showed that majority of the subjects (51%) were of the age group between 56 and 65 years, and 71% were male with CVD. 
Sleep disturbances were present in 80% of the subjects with CVD, among which 56% subjects had mild disturbances, 20% subjects with moderate 
sleep disturbances, and 4% subjects with severe sleep disturbances. The result also indicated that 48% of subjects had poor sleep quality. Findings 
also showed a highly statistically significant association between cardiomyopathy and sleep disturbances (p<0.001). Total cholesterol and low-density 
cholesterol levels were significantly associated with sleep disturbances (p<0.05). There is a highly significant association between sleep disturbances 
and quality of sleep (p<0.001), indicating that sleep disturbances can be one factor in decreasing the quality of sleep in patients with CVD.
Conclusion: The results of the study indicated that sleep disturbances were prevalent in patients with CVD and often hazardous to heart health. As 
health practitioner and other health-care providers have not focused major attention on the importance of sleep to health, the need for providing 
information to them and patients regarding the importance of improving the quality of sleep and identifying the sleep disturbances will call for action 
to bring sleep to the forefront of public health.
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INTRODUCTION
Sleep is essential for a healthy heart [1]. Irregular or insufficient sleep 
can ultimately endanger heart health. Almost everyone has trouble 
sleeping once in a while, but if occasional episodes of sleep escalate into 
an unhealthy night time routine, it will hamper the productivity and 
sap the patient’s quality of life. Studies show that, compared to sleep 
duration of 7 h, both short and long durations of sleep (≤ 5 and ≥ 9 h) 
were positively associated with cardiovascular disease (CVD) in a large, 
nationally representative sample of the US adults [2]. Many studies have 
shown the relationship between sleep apnea and CVD. It was identified 
and found that over an 8-year period, men with severe sleep apnea 
were 58% more likely to develop congestive heart failure than men 
without the nighttime breathing disorder. Poor sleeping as a result of 
changing work schedules or poor sleep habits can put at risk as well [3].
It is understood that sleeping too little causes disruptions in underlying 
health conditions and biological processes such as glucose metabolism, 
blood pressure, and inflammation. In the National Health Interview 
Survey 2004–2007, more than one-third of the population in the US was 
reported to have an abnormal sleep duration, defined as either a short 
or long sleep duration. Several studies have shown that, compared to 
7–8 h of sleep, both shorter and longer sleep durations are associated 
with CVD risk factors such as diabetes, hypertension, and obesity [3,4]. 
The cost of poor sleep is much greater, and it may have profound 
consequences for our long-term health. Research has revealed that 
people who consistently fail to get enough sleep are at an increased 
risk of chronic disease. Treating sleep as a priority, rather than a luxury, 
may be an important step in preventing a number of chronic medical 
conditions. Sleep complaints increase with age, and they are twice as 
prevalent in women compared to men [5].
Globally, in 2015, there were estimated 422.7 million prevalent cases 
of CVD which is recorded. Countries with the lowest age-standardized 
prevalence of CVD in 2015, all with <5000 cases per 100,000 
individuals, included Singapore, Japan, South Korea, Chile, Argentina, 
Uruguay, Canada, Australia, New Zealand, Ireland, Cyprus, Malta, Italy, 
Greece, and Israel. Countries in Western Europe, as well as the United 
States, the United Arab Emirates, and Nepal, all had only slightly higher 
prevalence. Countries with the highest age-standardized prevalence 
in 2015, all >9000 cases per 100,000 persons, included most countries 
in West Africa, Morocco, Iran, Oman, Zambia, Mozambique, and 
Madagascar [6].
In 2011, there were 82,771 deaths by acute myocardial infarction (MI) 
(AMI) in Brazil, 46.7% in the Southeast. Data from the USA estimate 
that there are approximately 525,000 new cases and 190,000 recurring 
cases of AMI yearly, with a mean age of 64.7 and 72.2 years for men and 
women, respectively, which shows the magnitude of the disease. Poor 
sleep quality and disorders are considered additional risk factors for 
CVD and AMI. Many authors point out that changes in the duration of 
sleep (<5 h and >9 h) are related to an increased risk of developing and/
or dying of coronary disease and AMI. Other studies show that <6 h of 
sleep per night, or <7½ h for diabetic patients, represent a higher risk 
for AMI [7].
In a prospective cohort study, duration of sleep equal to or higher than 
7 h, associated with other four lifestyle factors (physical activity, healthy 
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diet, moderate use of alcohol, and no smoking), was related to a lower 
risk of CVD. CVDs are the number one cause of death globally: More 
people die annually from CVDs than from any other cause. An estimated 
17.7 million people died from CVDs in 2015, representing 31% of all 
global deaths. Of these deaths, an estimated 7.4 million were due to 
coronary heart disease (CHD) and 6.7 million were due to stroke. Over 
three-quarters of CVD deaths take place in low- and middle-income 
countries [7]. India will soon bear the largest burden of heart disease 
globally: In India, of the estimated population of >1.27 billion dispersed 
across various geographical regions, about 45 million people suffer from 
coronary artery disease (CAD). ‘According to current estimates, India will 
soon have the highest number of cases of CVD in the world’, says Dr. Nikhil 
Kumar, Director, Cardiology, Fortis Memorial Research Institute, Gurgaon. 
It is estimated to account for 35.9% deaths by the year 2030 [8].
In Kerala, 14% of all deaths are caused by CHD/CAD. In Kerala, the 
prevalence of lifestyle diseases such as diabetes, heart disease, high blood 
pressure, and obesity is high, and it results in very high mortality and 
morbidity from malignant heart disease [8]. In Kerala, mortality rates for 
CAD per 100,000 are 382 for men and 128 for women which are actually 
3–6 times higher than Japanese and rural Chinese and also higher than 
other industrialized countries. Approximatelyw 60% of CAD deaths in men 
and 40% of CAD deaths in women occur before the age of 65 years that is 
at very young age. People from Kerala have the highest cholesterol level in 
India which ranges from 197 to 229 mg/dl compared to 157 to 180 mg/dl 
nationally. Kerala is known as the diabetes capital of India as the prevalence 
of diabetes is high, i.e., 20% which is double the national average of 8%. As 
compared, the prevalence in Thiruvananthapuram was 17%, in Hyderabad 
and New Delhi 15%, in Nagpur 4%, and in Dibrugarh 3% [9].
The cardiology unit of Amrita Institute of Medical Sciences and 
Research Centre, Kochi, has a monthly censes of the average of 797 new 
cases and 2919 revisits. The sleep laboratory studies in Amrita Institute 
of Medical Sciences and Research Centre, Kochi, have an yearly censes 
of 132 patients and among that 18 cases were patients with CVDs.
METHODS
A quantitative approach and a non-experimental descriptive design 
study was conducted in Cardiology out-patient department and 
cardiology ward of Amrita Institute of Medical Sciences and Research 
Centre, a tertiary care center hospital, Kochi, among 100 subjects using 
non-probability convenient sampling technique. The setting was selected 
because of the easy accessibility of the group, familiarity with setting, 
convenience in terms of adequate sample, and the cooperation offered 
by the management. The researcher explained the purpose of the study 
and obtained an informed consent from each subject. The tool for data 
collection include Tool I - Semi-structured questionnaire consists of two 
sections, Section I: Sociodemographic data and clinical data and Section II: 
Sleep disturbance questionnaire to assess the sleep disturbances among 
patients with CVDs, and Tool II - Pittsburgh Sleep Quality Index (PSQI) to 
assess the quality of sleep among patients with CVD. Data analysis was 
performed using descriptive and inferential statistics.
RESULTS
Section I: Description of sociodemographic variables of the 
subjects
The data presented in Table 1 is regarding the sociodemographic 
characteristics showed that, among the 100 subjects, 59 (59%) 
patients with CVDs were in the age group of 56–65 years, followed 
by 27 (27%) between 46 and 55 years, and 71 (71%) were males 
and 97 (97%) were married. Among the 100 subjects, 49 (49%) of 
them had high-school education, 35 (35%) of the subjects were 
employed, and maximum number of subjects 36 (36%) were having 
monthly income of greater than Rs. 15,000.
B: Description of sample characteristics based on clinical variables
The clinical variables include diagnosis, duration of cardiac illness, family 
history of cardiac illness and presence of co-morbidities, use of prescribed 
medications, habit of snoring, smoking habit, alcoholism, body mass index 
(BMI), neck circumference, waist-hip ratio, and intervention undergone.
The data presented in Table 2 regarding the clinical characteristics 
showed that the majority of the subjects, 44 (44%), had the duration of 
cardiac illness for >5 years, only 21 (21%) subjects had family history 
of cardiac illness, and 9 (9%) among the subjects had the habit of 
smoking; however, 27 (27%) stopped smoking and 11 (11%) subjects 
had the habit of alcoholism. Regarding the BMI, 61 (61%) subjects had 
a higher BMI than the normal range, of which 14 (14%) subjects were 
obese and nearly 47 (47%) subjects were overweight.
Table 1: Frequency and percentage distribution of subjects 
based on demographic characteristics, n=100






























Table 2: Distribution of subjects based on clinical 
characteristics, n=100
Clinical data Frequency (f) (%)
















Underweight (<18.50) 2 (2)
Normal range (18.50–24.99) 37 (37)
Overweight (≥25.0) 47 (47)
Obese (≥30.0) 14 (14)
BMI: Body mass index
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The data presented in Fig. 1 showed that 65 (65%) subjects had the 
habit of snoring.
The data presented in Fig. 2 showed that nearly 51 (51%) subjects 
were on conservative management, whereas 39 (39%) had undergone 
percutaneous transluminal coronary angioplasty for CVDs.
The data illustrated in Fig. 3 showed that majority of the subjects, 
70 (70%), were diagnosed with MI, 18 (18%) of the subjects had 
other forms of cardiac dysfunction, followed by 6 (6%) subjects having 
heart blocks, with only of 4 (4%) and 2 (2%) subjects diagnosed with 
cardiomyopathy and heart failure among patients with CVD.
Table 3 enumerates the data of sleep disturbances among patients with 
CVD, and among 100 subjects, 80 (80%) of them had sleep disturbances. 
56 (56%) had remarkably mild sleep disturbances, moderate sleep 
disturbances were seen in 20 (20%), and 4 (4%) subjects with CVD 
complained of severe sleep disturbances in the previous month.
Table 4 enumerates the level of sleep disturbances among subjects with 
the duration of cardiac illness. Among the 100 subjects, 16 subjects had 
<1 year of cardiac illness, of which 9 subjects had mild sleep disturbances, 
subjects with >5 years of cardiac illness 20 subjects had mild sleep 
disturbances, and 13 subjects had moderate sleep disturbances. 
Majority of the subjects, 56 (56%), had mild sleep disturbances, of which 
27 (48.2%) subjects had cardiac illnesses within 1–5 years’ duration.
Section II: Experience of sleep disturbances among patients with CVD
The data presented in Table 5 showed that, among 100 subjects, 
80 (80%) subjects mentioned symptoms of insomnia, 60 (60%) subjects 
had restless leg syndrome (RLS), 68 (68%) subjects complained of 
fatigue and nightmares, and 47 (47%) and 65 (65%) subjects were 
having dozing and snoring, respectively.
Section III: Quality of sleep among patients with CVDs
The data presented in Table 6 regarding the quality of sleep of patients 
with CVD showed that the global PSQI mean score is 6.41. Approximately 
more than half 66 (66%) subjects rated that their sleep quality is fairly 
good, whereas 17 (17%) subjects rated fairly bad. 38 (38%) subjects had 
16–30 min of sleep latency, but 14 (14%) subjects took >60 min to fall 
asleep from lying down with a mean sleep latency of 96 min. 6–7 h of 
sleep duration was reported by 42 (42%) subjects, 20 (20%) subjects 
reported 5–6 h of sleep duration, and 14 (14%) subjects had only <5 h 
of sleep. The habitual sleep efficacy was >85% for 61 (61%) subjects, 
whereas the sleep efficacy between 65% and 74% and <65% was present 
in 10 (10%) subjects each. 71 (71%) subjects reported mild sleep 
disturbances and 23 (23%) subjects rated moderate sleep disturbances; 
moreover, 2 (2%) subjects had severe sleep disturbances. Only 3 (3%) 
subjects used sleep medications three or more times in a week. Among 
the 100 subjects, 56 (56%) subjects complained of daytime dysfunction, 
of which, 34 (34%) subjects reported slight daytime dysfunction, 
whereas 5 (5%) subjects mentioned severe daytime dysfunction.
The data presented in Fig. 4 revealed that majority of the subjects, 
52 (52%), reported score between 0 and 5 indicating good quality of 
sleep and only 48 (48%) had score between 6 and 21 identifying poor 
quality of sleep.
Section IV: Association of sleep disturbances and selected variables
The association computed using Chi-square between the level of sleep 
disturbances and selected demographic variables is presented in Table 7, 
Fig. 1: Pie diagram showing habit of snoring among patients with 
cardiovascular diseases
Fig. 3: Cylindrical bar diagram showing the diagnosis of patients 
with cardiovascular diseases
Fig. 2: Pie diagram showing the intervention undergone among 
the patients with cardiovascular disease
Table 3: Level of sleep disturbances among patients with CVD, 
n=100
Level of sleep disturbances Frequency (f) (%)
No disturbances 20 (20)
Mild disturbances 56 (56)
Moderate disturbances 20 (20)
Severe disturbances 4 (4)
Very severe disturbances 0 (0)
CVD: Cardiovascular diseases
266
Asian J Pharm Clin Res, Vol 12, Issue 1, 2019, 263-268
 Merin and Antony 
and the data presented depict that there was association between gender 
and sleep disturbances (p<0.05), but there was no significant association 
between sleep disturbances and other demographic variables.
Section V: Association of Sleep Disturbances and Quality of Sleep
The data presented in Table 8 showed that there is a highly significant 
association between sleep disturbances and quality of sleep 0.0001 
(p<0.001).
Table 4: Distribution of subjects based on duration of cardiac illness and sleep disturbances, n=100
Sleep disturbances
Duration of cardiac illness (Year) No disturbances f (%) Mild disturbances f(%) Moderate disturbances f (%) Severe disturbances f (%)
<1 3 (15) 9 (16.1.48) 3 (15) 1 (25)
1.5 8 (40) 27 (2) 4 (20) 1 (25)
>5 9 (45) 20 (35.7) 13 (65) 2 (50)
Table 5: Distribution of subjects with CVD based on the clinical 
symptoms of sleep disturbances, n=100







CVD: Cardiovascular diseases, RLS: Restless leg syndrome
Table 6: Distribution of subjects based on the quality of sleep, 
n=100
Sleep Quality Frequency (f) (%) Mean±SD
Subjective sleep quality 1.31±0.873
Very good 10 (10)
Fairly good 66 (66)
Fairly bad 7 (7)
Very bad 17 (17)
Sleep latency 0.96±1.024
0 (<15 min) 40 (40)
1–2 (16–30 min) 38 (38)
3–4 (31–60 min) 8 (8)
5–6 (>60 min) 14 (14)
Sleep duration 1.24±0.976
>7 h 24 (24)
6–7 h 42 (42)
5–6 h 20 (20)
<5 h 14 (14)










Use of sleep medications 0.15±0.592
Not during the past month 93 (93)
Less than once a week 2 (2)
Once or twice a week 2 (2)










The present study findings implicate that the subjects with CVD were 
of the age group of 36–75 years and 80 (80%) subjects had sleep 
disturbances with majority of the subjects 56 (56%) having mild sleep 
disturbances, and only 4 (4%) had severe sleep disturbances. Majority 
of the 80 (80%) subjects had reported manifestations of insomnia, 
followed by 68 (68%) subjects complained of both fatigue and 
nightmares; moreover, snoring was reported by 65 (65%) subjects and 
60 (60%) subjects mentioned about manifestations of RLS. Moreover, 
the subjects with cardiomyopathy showed a significant association of 
sleep disturbances (p<0.001). It was worth noticing sleep disturbances 
present nearly more than half of the subjects with CVD at various level 
from mild to severe.
The study findings are supported by Michal et al. who reported that sleep 
disturbances were present in 73.6% of subjects out of 10,000 patients 
with CVD aged between 35 and 74 years [10].
Another study reported by Shankar A, on insufficient rest or sleep and 
its relation to CVD also supported the study, where 11% reported all 
30 days of insufficient sleep in the past month [11]. In comparing the 
present study with the reported studies, it can be interpreted that the 
prevalence of sleep disturbances occurs in subjects with CVD, which 
ranged from 55 to 65%.
A cross-sectional study in 2017 on prevalence and determinants of 
insomnia after a MI among 209 subjects was conducted by Da Costa 
et al. The findings showed that overall 36% of the sample reported 
clinical symptoms of insomnia. Among the patients after MI, 62.7% 
subjects which was a higher proportion were experiencing insomnia 
with depressed mood when compared to good sleepers (13.4%) [12]. 
This reported study findings support the present study, indicating that 
insomnia is a major concern of sleep disturbances among CVD patients.
From the above studies, it is evident that sleep disturbances are present 
among patients with CVDs. Sleep disturbances had increased risk of 
developing or dying from CHD.
The results of this study show that, among the 100 subjects with CVDs, 
about 48 (48%) had poor sleep quality, whereas 52 (52%) have good 
sleep quality and the global PSQI mean score is 6.41. 34 (34%) subjects 
Fig. 4: Bar diagram showing the Pittsburgh sleep quality index 
global score of patients with cardiovascular diseases
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Table 7: Association between sleep disturbances and selected demographic variables, n=100












χ2 df p value
Age (in years) 10.462 9 0.314ns
36–45 1 5 4 7.1 0 0 0 0
46–55 8 40 10 17.9 8 40 1 25
56–65 10 50 35 62.5 12 60 2 50
66–75 1 5 7 12.5 0 0 1 25
Gender 8.312 3 0.040*
Male 15 75 44 78.6 11 55 1 25
Female 5 25 12 21.4 9 45 3 75
Education 12.383 12 0.415ns
Primary 1 5 7 12.5 0 0 0 0
High school 9 45 22 39.3 15 75 3 75
Pre‑degree/plus‑two/equivalent 4 20 10 17.9 1 5 1 25
Graduate 5 25 15 26.8 4 20 0 0
Postgraduate 1 5 2 3.6 0 0 0 0
Marital status 0 5.604 6 0.469ns
Single 20 0 2 3.6 0 0 0 0
Married 0 100 54 96.4 19 95 4 100
Widow/widower 0 0 0 1 5 0 0
*significant (p<0.05), ns=No significant
Table 8: Association of sleep disturbances and quality of sleep, n=100
Type of sleep disturbances quality of sleep Good (f) Poor (f) χ2 df p value
No disturbances 18 90 2 10 24.164 3 0.0001*
Mild disturbances 30 53.6 26 46.4
Moderate disturbances 4 20 16 80
Severe disturbances 0 0 4 100
*Highly significant (p<0.001)
mentioned <6 h of sleep duration, and the findings also show that poor 
quality of sleep was present among subjects with <6 h of sleep odds 
ratio=0.07 (95% confidence interval: 4.40–64.05, p<0.0001) when 
comparing with subjects who are sleeping 6–8 h, and there is a highly 
statistically significant association between short sleep duration <6 h 
with quality of sleep.
The study findings were supported on the result of the retrospective 
control study conducted by Sharma, which showed that both poor quality 
of sleep and short sleep duration should be independently associated 
with CAD. Poor sleep quality (PSQI >5) was 16.62 (9.13–30.28) among 
352 adult subjects (176 controls and 176 cases) [13]. This suggests that 
poor sleep quality and short sleep duration may be important modifiable 
CAD risk factors in the Indian population.
Chen HM, conducted a study on self-reported health-related quality of 
life and sleep disturbances among 125 heart failure participants. PSQI 
was used, and the mean score is 9.06. 93 (74.4%) participants were 
identified as poor sleepers, which is justifying the results of the present 
study [14].
Andrechuk and Ceolim study on sleep quality in patients with AMI 
among 113 subjects reported that 71.7% of subjects with AMI had 
frequent poor sleep quality according to the PSQI [7].
On comparing the study results with the above-mentioned study, it 
is evident that poor sleep quality was present in patients with CVDs. 
In the present study, 48 (48%) had poor quality of sleep and it can be 
interpreted as the quality of sleep among patients with CVD is poor. 
Many studies shown the relationship between sleep apnea and CVD [15].
CONCLUSION
The epidemiological and pathophysiological literature indicate that 
there may be a causal link between primary sleep abnormalities and 
cardiovascular and metabolic diseases. Moreover, it is not adequately 
addressed by the health-care fraternity and patients are also unaware 
about its importance.
Further understanding of specific pathophysiological pathways linking to 
sleep disorders to CVD is important for developing therapeutic strategies, 
and the present study provides an insight to the health-care community 
which has an important implication for cardiovascular health.
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